{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:03Z","timestamp":1786119123665,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12,27]]},"DOI":"10.1097\/tp.0b013e3181910eb2","type":"journal-article","created":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T03:19:57Z","timestamp":1229311197000},"page":"1771-1776","source":"Crossref","is-referenced-by-count":24,"title":["Safety and Efficacy of Statin Therapy in Patients Switched From Cyclosporine A to Sirolimus After Cardiac Transplantation"],"prefix":"10.1097","volume":"86","author":[{"given":"Arezu Z.","family":"Aliabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Mahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Dunkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gr\u00f6mmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zimpfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Wolner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas O.","family":"Zuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210129","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.healun.2007.06.004","article-title":"Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplantation report-2007.","volume":"26","author":"Taylor","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R2-27-20210129","first-page":"56","article-title":"Clinical and laboratory correlates of accelerated coronary disease in cardiac transplant patients.","volume":"76","author":"Gao","year":"1987","journal-title":"Circulation"},{"key":"R3-27-20210129","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.healun.2006.05.001","article-title":"Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients.","volume":"25","author":"Kobashigawa","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R4-27-20210129","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0041-1345(02)03103-2","article-title":"Low incidence of graft arteriosclerosis after cardiac transplantation: Risk factor analysis for patients with induction therapy.","volume":"34","author":"Zuckermann","year":"2002","journal-title":"Transplant Proc"},{"key":"R5-27-20210129","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation.","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"R6-27-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.CIR.0000043241.32523.EE","article-title":"Simvastatin early after heart transplantation: 8-year prospective experience.","volume":"107","author":"Wenke","year":"2003","journal-title":"Circulation"},{"key":"R7-27-20210129","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0735-1097(02)02340-9","article-title":"Comparative beneficial effects of simvastatinand pravastatin on cardiac allograft rejection and survival.","volume":"40","author":"Mehra","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R8-27-20210129","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1053-2498(00)00077-2","article-title":"Efficacy and safety vs. simvastatin after cardiac transplantation.","volume":"19","author":"Keogh","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"R9-27-20210129","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten\u2013year follow-up of a randomized trial of pravastatin in heart transplant patients.","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R10-27-20210129","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy.","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"R11-27-20210129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.healun.2005.09.009","article-title":"Localized rhabdomyolysis after exertion in a cardiac transplant recipient on statin therapy.","volume":"25","author":"Biggs","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R12-27-20210129","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/S0041-1345(99)00445-5","article-title":"Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine.","volume":"31","author":"Rodiguez","year":"1999","journal-title":"Transplant Proc"},{"key":"R13-27-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/aapsj060428","article-title":"Exposure-response relationships and drug interactions of sirolimus.","volume":"6","author":"Zimmermann","year":"2004","journal-title":"AAPS Journal"},{"key":"R14-27-20210129","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1600-6143.2007.02142.x","article-title":"Development of proteinuria after switch to sirolimus-based immnosuppression in long-term cardiac transplant patients.","volume":"8","author":"Aliabadi","year":"2008","journal-title":"Am J Transplant"},{"key":"R15-27-20210129","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial.","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"R16-27-20210129","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"R17-27-20210129","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.TP.0000103740.98095.14","article-title":"Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure.","volume":"77","author":"Groetzner","year":"2004","journal-title":"Transplantation"},{"key":"R18-27-20210129","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.healun.2005.08.015","article-title":"Sirolimus in cardiac transplantation: Use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.","volume":"24","author":"Kushwaha","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R19-27-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"},{"key":"R20-27-20210129","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).","volume":"81","author":"Jones","year":"1998","journal-title":"Am J Cardiol"},{"key":"R21-27-20210129","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1345\/aph.1D391","article-title":"Approximate equivalent rosuvastatin doses for temporary statin interchange programs.","volume":"38","author":"Kendrach","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R22-27-20210129","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/CIRCULATIONAHA.107.692996","article-title":"Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.","volume":"116","author":"Raichlin","year":"2007","journal-title":"Circulation"},{"key":"R23-27-20210129","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholersterolemia. West of Scotland coronary prevention study group.","volume":"333","author":"Shepard","year":"1995","journal-title":"N Engl J Med"},{"key":"R24-27-20210129","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Prtotection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomized placebo-controlled trial.","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"R25-27-20210129","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0022-5223(95)70191-5","article-title":"Cardiac transplant coronary disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events.","volume":"109","author":"McGiffen","year":"1995","journal-title":"J Thoac Cardiovasc Surg"},{"key":"R26-27-20210129","first-page":"1337","article-title":"The Canadian Study of Cardiac Transplantation. Atherosclerosis. Invstigators of the CASCADE Study.","volume":"15","author":"Carrier","year":"1999","journal-title":"Can J Cardiol"},{"key":"R27-27-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ahj.2004.03.050","article-title":"Treatment of hyperlipidemia in cardiac transplant recipients.","volume":"148","author":"Bilchik","year":"2004","journal-title":"Am Heart J"},{"key":"R28-27-20210129","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators.","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"R29-27-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: A randomized placebo controlled trial.","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"R30-27-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9149(03)00456-9","article-title":"Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction.","volume":"92","author":"See","year":"2003","journal-title":"Am J Cardiol"},{"key":"R31-27-20210129","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1399-3046.2007.00827.x","article-title":"Prevention of pediatric graft coronary artery disease: Atorvastatin.","volume":"12","author":"Chin","year":"2008","journal-title":"Pediatr Transpant"},{"key":"R32-27-20210129","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0735-1097(01)01430-9","article-title":"Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation.","volume":"38","author":"Weis","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R33-27-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0966-3274(02)00030-8","article-title":"Statins as immunmodulators.","volume":"9","author":"Mach","year":"2002","journal-title":"Transpl Immunol"},{"key":"R34-27-20210129","first-page":"335","article-title":"The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.","volume":"17","author":"Katznelson","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"R35-27-20210129","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1053-2498(00)00128-5","article-title":"Role of statins in the management of dyslipidemia after cardiac transplant: Randomized controlled trial comparing the efficacy and safety of atorvastatin with pravastatin.","volume":"19","author":"Magnani","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"R36-27-20210129","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1053-2498(01)00369-2","article-title":"Safety and efficacy of atorvastatin in heart transplant reciepients.","volume":"21","author":"Patel","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R37-27-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/TP.0b013e318177281e","article-title":"Beneficial effect of Omega-3 fatty acids on sirolimus- or everolimus- induced hyertriglyceridemia in heart transplant recipients.","volume":"86","author":"Celik","year":"2008","journal-title":"Transplantation"},{"key":"R38-27-20210129","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.transproceed.2006.02.071","article-title":"Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice.","volume":"38","author":"Grigioni","year":"2006","journal-title":"Transplant Proc"},{"key":"R39-27-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/00912700222011148","article-title":"Pharmakokinetic and pharmakodynamic assessments of HMG-Coa reductase inhibitors when coadminitered with everolimus.","volume":"42","author":"Kovarik","year":"2002","journal-title":"J Clin Pharmacol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e3181910eb2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:29:25Z","timestamp":1786037365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200812270-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,27]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181910eb2","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12,27]]}}}